Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated enzyme-CAS holds great promise for treating many uncured human diseases and illnesses by precisely correcting harmful point mutations and disrupting disease-causing genes. The recent Food and Drug Association (FDA) approval of the first CRISPR-based gene therapy for sickle cell anemia marks the beginning of a... https://zhudssizymoii.timeblog.net/70687943/hepatitis-b-virus-induces-il-23-production-in-antigen-presenting-cells-and-causes-liver-damage-via-the-il-23-il-17-axis